Skip to main content
. Author manuscript; available in PMC: 2023 Jun 23.
Published in final edited form as: J Clin Pathw. 2023;9(1):22–28. doi: 10.25270/jcp.2023.01.02

Table 1.

Proposed process for sequential evaluation and treatment of patients presenting with post–COVID-19 syndrome dyspnea or cough

Recommended Optional
History
History of Present Illness

  1. When symptoms started

  2. When/how diagnosed

  3. Current supplemental oxygen use (Y/N)

  4. Vaccination status

  5. Booster

  1. When acute illness resolved

  2. Treatments (Y/N)
    1. Azithromycin
    2. Corticosteroids
    3. Monoclonal antibody
    4. Convalescent plasma
    5. Remdesivir
    6. Nirmatrelvir/Ritonavir
    7. Tocilizumab
  3. Hospitalization
    1. ICU stay (Y/N)
    2. Mechanical ventilation (Y/N)
    3. High-flow nasal oxygen or noninvasive ventilation (Y/N)
    4. Duration (days)
Past Medical History History of pulmonary/cardiac disease

  1. Pulmonary (asthma, COPD, ILD, OSA)

  2. Cardiac (CAD, CHF)

  3. Mental Health (PTSD, GAD, MDD)

  4. Other (Obesity)
Current Symptoms
Dyspnea At rest
On exertion
Cough Dry/productive
Nocturnal
Negatives Chest pain
Leg edema
Palpitations
PND/orthopnea

Abbreviations: CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; GAD, generalized anxiety disorder; ICU, intensive care unit; ILD, interstitial lung disease; MDD, major depressive disorder; OSA, obstructive sleep apnea; PND, paroxysmal nocturnal dyspnea; PTSD, posttraumatic stress disorder.